Walgreens May Sales Increase 4.3 Percent
June 05 2013 - 8:00AM
Business Wire
Walgreens (NYSE: WAG) (Nasdaq: WAG) had May sales of $6.22
billion, an increase of 4.3 percent from $5.97 billion for the same
month in fiscal 2012.
Total front-end sales increased 3.4 percent compared with the
same month in fiscal 2012, while comparable store front-end sales
increased 1.2 percent. Customer traffic in comparable stores
decreased 3.5 percent while basket size increased 4.7 percent.
Prescriptions filled at comparable stores increased by 7.1
percent in May and increased 7.5 percent on a calendar day-shift
adjusted basis. This year’s May had one additional Friday and one
fewer Tuesday compared with May 2012. These calendar shifts
negatively impacted prescriptions filled at comparable stores by
0.4 percentage point.
The company said the percentage of former Express Scripts
prescriptions returning to its pharmacies continued to increase in
May.
May pharmacy sales increased by 4.4 percent, while comparable
store pharmacy sales increased 3.8 percent and increased by a
calendar day-shift adjusted 4.2 percent. Calendar day shifts
negatively impacted pharmacy sales in comparable stores by 0.4
percentage point. Calendar day-shift adjusted comparable store
pharmacy sales were negatively impacted by 3.7 percentage points
due to generic drug introductions in the last 12 months. Pharmacy
sales accounted for 63.1 percent of total sales for the month.
Sales in comparable stores increased by 2.8 percent in May.
Calendar day shifts negatively impacted total comparable sales by
0.3 percentage point, while generic drug introductions in the last
12 months negatively impacted total comparable sales by 2.3
percentage points.
Registrations for Walgreens Balance® Rewards loyalty program,
which launched in September, totaled more than 72 million through
May.
Total sales for the third quarter of fiscal 2013 were $18.34
billion, up 3.3 percent from $17.75 billion in the third quarter of
fiscal 2012. Comparable store sales for the third quarter of fiscal
2013 increased 1.3 percent, while front-end comparable store sales
for the quarter increased 0.3 percent. Prescriptions filled at
comparable stores increased 7.0 percent in the third quarter and
comparable pharmacy sales increased 2.0 percent.
Calendar 2013 sales to date were $30.27 billion, an increase of
2.9 percent from $29.41 billion in 2012.
Fiscal 2013 year-to-date sales for the first nine months were
$54.30 billion, down 0.5 percent from $54.56 billion in the
comparable period in fiscal 2012.
Walgreens opened 13 stores during May, including two
relocations, and closed one.
On May 31, Walgreens operated 8,560 locations in all 50 states,
the District of Columbia, Puerto Rico and Guam. That includes 8,096
drugstores, 207 more than a year ago, including 70 net stores
acquired over the last 12 months. The company also operates
infusion and respiratory services facilities, specialty pharmacies
and mail service facilities. Its Take Care Health Systems
subsidiary manages more than 700 in-store convenient care clinics
and worksite health and wellness centers.
May Comparable Sales and Prescriptions Filled
Cough,
Calendar
Generics
Cold, Flu
Actual
Shift
Impact
Impact
Impact
Total Comp Sales 2.8 % -0.3 % -2.3 % 0.1 % Comp Front
End 1.2 % - - - Comp Rx Sales 3.8 % -0.4 % -3.7 % 0.1 %
Comp Rx Scripts
7.1
%
*
-0.4 % - 0.2 %
* Includes +1.5 percentage points from patients filling more
90-day prescriptions
Please note: Sales numbers and the adjustments shown in the
table are preliminary, unaudited and subject to revision.
Comparable stores are defined as those drugstore locations open for
at least 12 consecutive months without closure for seven or more
consecutive days and without a major remodel or a natural disaster
in the past 12 months. Acquired operating locations and relocations
are not included as comparable stores for the first 12 months after
the acquisition or relocation.
Cautionary Note Regarding Forward-Looking Statements: Statements
in this release that are not historical are forward-looking
statements made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Words such as
"expect," “likely,” "outlook," “forecast,” "would," "could,"
"should," “can,” “will,” "project," "intend," "plan," "goal,”
“target,” “continue," "sustain," “synergy,” "on track," "believe,"
"seek," "estimate," "anticipate," "may," “possible,” "assume," and
variations of such words and similar expressions are intended to
identify such forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve
risks, assumptions and uncertainties, including, but not limited
to, those described in Item 1A (Risk Factors) of our most recent
Annual Report on Form 10-K and Quarterly Report on Form 10-Q, each
of which is incorporated herein by reference, and in other
documents that we file or furnish with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect,
actual results may vary materially from those indicated or
anticipated by such forward-looking statements. Accordingly, you
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date they are made. Except
to the extent required by law, Walgreens does not undertake, and
expressly disclaims, any duty or obligation to update publicly any
forward-looking statement after the date of this report, whether as
a result of new information, future events, changes in assumptions
or otherwise.
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jun 2024 to Jul 2024
West Africa Gold (NASDAQ:WAGI)
Historical Stock Chart
From Jul 2023 to Jul 2024